gemcitabine and oxaliplatin. Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Also known as: GemOx, Gemzar(Eli Lilly and Company) and Aiheng(Jiangsu Hengrui Medicine Co., Ltd.)

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

Taylor Brooks1
Shanghai Jiao Tong University School of Medicine1

Indications

Cancer2
Cytokine Release Syndrome1
Non-hodgkin Lymphoma1
Gallbladder Carcinoma1

Other1 trial

Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA

Phase 2

Cleveland, Ohio1 trial

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.